Relying on a highly integrated industrialization and transformation technology platform and GMP production capacity, we provide biologic macromolecule drugs that meet international quality standards and have controllable costs
For detailed information about our CMC and manufacturing capabilities, please refer to our subsidiary, Foster Bio, an independently operated CDMO service provider.You can visit Foster Bio's website: http://www.fosterbio.com/
